Cynthia D. Brown

机构：Indiana University – Purdue University Indianapolis · ORCID：0000-0003-4057-0561

发表论文 82 篇 · 总被引 2526 次 · h-index 20

代表论文

• Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study (2023 · Journal of Cystic Fibrosis · 被引 153)
• Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials (2023 · The Lancet Respiratory Medicine · 被引 73)
• Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis (2024 · Journal of Cystic Fibrosis · 被引 21)
• Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor (2023 · International Journal of Neonatal Screening · 被引 19)
• Risk of COVID-19 after natural infection or vaccination (2023 · EBioMedicine · 被引 14)
• A survey assessing the impact of COVID‐19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis (2022 · Pediatric Pulmonology · 被引 14)